Navigation Links
The genetic X-factor
Date:4/19/2009

A collaboration between more than 70 researchers across the globe has uncovered nine new genes on the X chromosome that, when knocked-out, lead to learning disabilities. The international team studied almost all X chromosome genes in 208 families with learning disabilities - the largest screen of this type ever reported.

Remarkably, the team also found that approximately 1𔃀% of X chromosome genes, when knocked-out, have no apparent effect on an individual's ability to function in the ordinary world. The publication in Nature Genetics - a culmination of five years of scientific collaboration - emphasises the power of sequencing approaches to identify novel genes of clinical importance, but also highlights the challenges researchers face when carrying out this kind of study.

Estimates suggest that the prevalence of learning disability is 2𔃁%. Learning disability is significantly more common in males than in females and genetic causes have long been sought on the X chromosome: males have only one X chromosome and so a gene mutation on the X is more likely to have an effect in males than in females.

"We sequenced 720 out of the approximately 800 known genes on the X chromosome in more than 200 families affected by X-linked learning disabilities," explains Professor Mike Stratton, from the Wellcome Trust Sanger Institute. "This is the largest sequencing study of complex disease ever reported."

In part because of their apparent effects in males, X-linked disorders have been well studied by geneticists over the past 25 years. Conceived by Dr Lucy Raymond, from the University of Cambridge, and Professor Mike Stratton, the collaborative study harnessed DNA sequencing to detect as many new abnormal genes as possible. In the future similar strategy will be used to find disease causing sequence variants implicated in other complex genetic diseases.

Some characteristics in common could be identified in patie
'/>"/>

Contact: Don Powell
don@sanger.ac.uk
44-012-234-96928
Wellcome Trust Sanger Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Genetic switch potential key to new class of antibiotics
2. Joint statement by German science organizations on green genetic engineering
3. New nucleotide could revolutionize epigenetics
4. For cancer cells, genetics alone is poor indicator for drug response
5. Is love at first sight real? Geneticists offer tantalizing clues
6. Major aspergillus genomics supplement published by journal Fungal Genetics and Biology
7. Ali Shilatifard and colleagues aim to clarify the definition of epigenetics
8. Researchers examine bacterial rice diseases, search for genetic solutions
9. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
10. Bad mix of bacterial remnants and genetics leads to arthritis
11. Margarita Saenz, M.D. is recipient of Genzyme/ACMGF Fellowship in Biochemical Genetics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... December 1, 2009: OptiNose is pleased to announce...ical study investigating the efficacy and tolerabi...for the topical treatment of chronic rhinosinusiti...ournal of the International and European Rhinologi...l polyps is a chronic disease that can significant...
(Date:12/1/2009)... This release is available in German . , Bro.... It contains loads of mitochondria, miniature po...at. In doing this, they normally generate a voltag...s energy for cellular processes. However, the mito...They go full steam ahead all the time. The energy ...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Wound Management Technologies Acquires Resorbable Orthopedics 5146 1Wound Management Technologies Acquires Resorbable Orthopedics 5146 2Wound Management Technologies Acquires Resorbable Orthopedics 5146 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 1Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 2Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 4
...ent has awarded five faculty planning grants to de... help solve the world,s urgent demands for fresh w... and well-being, yet in poor countries more than a...ies, and more than 2 billion lack basic sanitation...ichard Luthy, a professor of civil and environment...
...ther nature or nurture determines an ant,s status ...oth. , Nature (that is, the ant,s genetic makeup)...le in determining the fate of the Florida harveste...ound in many parts of the southeastern United Stat...the University of Illinois, the University of Ariz...
...dical Center immunologist and blood and marrow tra...e as the study co-chair for a new national clinica...rd blood transplants for severe sickle cell dise...ther medical institutions in the first-ever Phase ..., the Sickle Cell Unrelated Transplant (SCURT) tri...
Other Biology News:New planning grants to fund research on freshwater issues 2New planning grants to fund research on freshwater issues 3Genes and nutrition influence caste in unusual species of harvester ant 2Genes and nutrition influence caste in unusual species of harvester ant 3Children's national co-leads nationwide study of landmark sickle cell treatment 2
(Date:12/1/2009)... , iCardiac now provides ...utical companies. , Roche...nologies, Inc., a global leader in advanced cardia...ay that a top five pharmaceutical company has sele...b services. iCardiac will provide Highly Automate...
(Date:12/1/2009)... , Michael R. Drapp, a 34... formed nanoEdge™ Technologies, a business d...mpany focused on the emerging nanotechnology space...echnologies and act as a nanotechnology incubator....ecember 1, 2009 -- Michael R. Drapp , a 34-year v...
(Date:11/30/2009)... , , Cambridge, Mass November 30, 2009 An inter...Hamamatsu Photonics, and ETH Zrich have demonstrat... emitting in the invisible part of the light spect... single light beam of a well-defined wavelength. T...in applications related to remote chemical sensing...
(Date:11/30/2009)... , , BLOOMINGTON, Minn., Nov. 30 /PRNewsw...ormance medical image management software, data mi...cting with Allina Hospitals and Clinics for a new ...tion of image storage across the Allina network of...iving solution is based on the Acuo Technologies D...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3
...Revenues Up 61%, Six-Month Net Revenues Up 40%, ET...arter and 67% for Six ...% for Second Quarter and 14% for Six ... Pharmaceutical Company,(NYSE: KVa/KVb) today repo...ng revenue and earnings growth for the second quar...
...Nov. 19 Beckman Coulter,Inc. (NYSE: BEC ), a lea...ucts that simplify, automate, and innovate complex...ynor, Beckman Coulter,s director of investor,relat...y Healthcare,Conference on Wednesday, November 28,...com.com/cgi-bin/prnh/20031202/BECLOGO ) The live ...
.... 19 Advanced Instruments, Inc., of,Norwood, Mass...0% of the,shares of Mart Microbiology B.V. of The ... disclosed. Mart Microbiology manufactures and ma...systems create custom environments for anaerobic,b...en-deprived atmospheres.,Typical applications incl...
Other Biology Technology:KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 2KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 3KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 4KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 5KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 6KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 7KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 8KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 9KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 10Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference 2Advanced Instruments Acquires Mart Microbiology B.V. 2
DTT 50 l from BD Biosciences Pharmingen
pRSET-E Echo Expression Vector Kit from Invitrogen
arrayWoRxe from Applied Precision, LLC
TopSpot E non-contact microarrayer from Parallabs
Biology Products: